NCT01159067 2019-06-18Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadCity of Hope Medical CenterPhase 2 Terminated1 enrolled 4 charts
NCT01273766 2018-09-07Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesWake Forest University Health SciencesPhase 2 Completed16 enrolled 10 charts
NCT00602446 2017-12-28Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 2 Terminated4 enrolled 5 charts
NCT02413021 2016-02-25The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy RegimensIsfahan University of Medical SciencesPhase 1 Unknown40 enrolled